Compare Novavax Inc (NVAX) vs iShares Semiconductor ETF (SOXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs iShares Semiconductor ETF — how do they compare? Novavax Inc trades at $9.84 (market cap $1.62B), while iShares Semiconductor ETF trades at $525.08. Which is the better fit depends on your goals.
| NVAX | SOXX | |
|---|---|---|
Market Cap | $1.62B | — |
Sector | Health | Sector/Thematic |
52-Week High | $11.19 | $655.01 |
52-Week Low | $6.22 | $253.45 |
Enterprise Value | $1.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $10.19, down 0.29% today, with a bullish technical signal from moving averages but overbought RSI levels. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 revenue outlook. Key developments include regulatory approvals for its updated COVID-19 vaccine in the U.S., EU, and Japan for the 2026-2027 season, alongside ongoing partnerships with Sanofi and Pfizer.
The outlook is mixed: strong analyst buy ratings (73.9%) and partnership milestones offer upside, but negative net income margins and cash flow challenges pose risks. Investors should weigh the potential from vaccine demand and adjuvant platform royalties against financial sustainability concerns and competitive pressures in the biotech sector.
SOXX trades at $528.40, up 1.64% with a bullish technical signal from moving averages and neutral oscillators. Recent news highlights strong AI-driven semiconductor demand, with institutional buying noted. A 1:3 stock split is scheduled for November 2026, and a $0.28 dividend is set for June 2026, reflecting corporate confidence.
The ETF benefits from AI infrastructure growth but faces risks from potential tariffs and market volatility. Analyst sentiment is positive due to sector tailwinds, though overcrowded positioning may cause near-term pressure. Long-term prospects remain strong driven by chip demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →
